Brunner-Ziegler Sophie, Hammer Alexandra, Seidinger Daniela, Willfort-Ehringer Andrea, Koppensteiner Renate, Steiner Sabine
Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria,
Wien Klin Wochenschr. 2015 Jul;127(13-14):549-54. doi: 10.1007/s00508-015-0798-3. Epub 2015 May 21.
Though the pathophysiology of initiation, formation, and expansion of abdominal aortic aneurysm (AAA) has been intensely researched, the distinct mechanisms driving these processes still remain unclear. In particular, human studies on predictors of AAA progression as a major determinant of rupture risk are scarce.
All consecutive abdominal aortic ultrasound sonographic examinations performed at the duplex laboratory of the Division of Angiology of the Medical University of Vienna between 1999 and 2012 were reviewed. Patients with repeated measurements of the infrarenal aortic diameter, who had no prior AAA repair were included. Detailed informations on AAA, including length, anterior-posterior and transversal measurements of diameter, and intraluminal thrombus formation/size were obtained from ultrasound examination; patients' comorbidities, cardiovascular risk factors, and medications were obtained from outpatient charts. The expansion rate of AAA in relation to intraluminal thrombus size, gender, age, comorbidities, cardiovascular risk factors, and pharmacotherapy was evaluated. Independent predictors of AAA growth were identified through mixed effects models.
In total, 166 patients (123 men and 43 women, mean age 68 ± 9 years) were included. Patients were followed over a mean period of 1.4 ± 1.2 years with a mean number of follow-up investigations of 4.4 ± 2.7. Overall, mean maximum AAA diameter at baseline was 37.4 ± 8.2 mm. The average expansion rate of AAA diameter throughout the follow-up period was 2.0 mm per year (95 % confidence interval: 1.6-2.4). At initial investigation, intraluminal thrombus formation was present in 56.6 % of all patients. AAA diameter at baseline, time of follow-up as well as presence and size of intraluminal thrombus formation were identified as independent predictors of AAA expansion rate. Importantly, gender and presence of cardiovascular risk factors were not associated with AAA progression rate.
Intraluminal thrombus formation seems to be a key determinant for progression of AAA diameter. Further prospective longitudinal studies are warranted to confirm the potential impact of thrombus formation on AAA development and its implication on monitoring and treatment decisions in patients with AAA.
尽管腹主动脉瘤(AAA)起始、形成和扩张的病理生理学已得到深入研究,但驱动这些过程的具体机制仍不清楚。特别是,关于AAA进展的预测因素作为破裂风险的主要决定因素的人体研究很少。
回顾了1999年至2012年在维也纳医科大学血管病学系双功超声实验室进行的所有连续性腹主动脉超声检查。纳入了对肾下腹主动脉直径进行重复测量且未进行过AAA修复的患者。从超声检查中获取有关AAA的详细信息,包括长度、前后径和横径测量以及腔内血栓形成/大小;从门诊病历中获取患者的合并症、心血管危险因素和用药情况。评估了AAA扩张率与腔内血栓大小、性别、年龄、合并症、心血管危险因素和药物治疗的关系。通过混合效应模型确定AAA生长的独立预测因素。
共纳入166例患者(123例男性和43例女性,平均年龄68±9岁)。患者平均随访1.4±1.2年,平均随访次数为4.4±2.7次。总体而言,基线时AAA的平均最大直径为37.4±8.2mm。随访期间AAA直径的平均扩张率为每年2.0mm(95%置信区间:1.6 - 2.4)。在初次检查时,所有患者中有56.6%存在腔内血栓形成。基线时的AAA直径、随访时间以及腔内血栓形成的存在和大小被确定为AAA扩张率的独立预测因素。重要的是,性别和心血管危险因素的存在与AAA进展率无关。
腔内血栓形成似乎是AAA直径进展的关键决定因素。有必要进行进一步的前瞻性纵向研究,以证实血栓形成对AAA发展的潜在影响及其对AAA患者监测和治疗决策的意义。